C&EN11h
How a hypertension drug can save limbs from frostbite
When frostbitten limbs warm up again, blood rushes back into the tissue. With that blood come compounds such as histamines ...
Pulmonaryhypertensionnews.com18h
Winrevair excels at advanced PAH in Phase 3 trial, all offered treatment
Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...
Science Daily1d
Cellular 'power plants' control inflammation
Researchers discover how mitochondria not only produce energy but also influence inflammation.
GlobalData on MSN1d
MSD’s trial of drug for pulmonary arterial hypertension meets primary endpoint
An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.
Le Lézard2d
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIRtm (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
Merck , known as MSD outside of the United States and Canada, announced today positive topline results from the Phase 3 ZENITH study evaluating WINREVAIR (sotatercept-csrk) in adults with pulmonary ...
Merck's therapy for rare lung condition shown to help reduce risk of death in study
Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...
pulmonologyadvisor5d
GOLD COPD 2025 Report: Key Spirometry and Drug Updates, New Emphasis on CVD, PH
The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...
Physician offers tips for living with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, or COPD, is a leading cause of disability and death in the U.S., according to the ...